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To the Editor: The phenotype of patients with various forms
of congenital lipodystrophy has indicated that proper storage
of triacylglycerol in peripheral adipocytes is essential to
prevent formation of ectopic fat deposits and development of
type 2 diabetes [1]. A similar situation with induced peri-
pheral lipodystrophy and elevated risk for type 2 diabetes is
seen in patients undergoing highly active anti-retroviral the-
rapy (HAART). In these patients, there is a 30–50% decline
in mitochondrial copy number as a result of HAART [2].
Basedontheseandotherobservations,wehaverecentlyput
forward the hypothesis that one of the functions of mitochon-
dria in adipose tissue is to prevent leakage of fatty acids into
the circulation [3]. This mitochondrial activity attenuates the
development of ectopic triacylglycerol deposits in the liver
and other tissues that would otherwise contribute to the
development of whole body insulin resistance and pancreatic
beta cell damage. Mitochondria contribute to efficient
confinement of fatty acids within adipocytes by oxidative
removal of fatty acids, liberated from the triacylglycerol pool,
by uncoupled beta oxidation. In addition, mitochondria may
provide glyceroneogenic substrates, which contribute to re-
esterification of fatty acids. As a net result, there are less fatty
acids available to the circulation for redistribution to other
compartments of the body [3]. A recent study provided
supporting evidence for this concept by showing that the
mitochondrial DNA copy number in human adipocytes is
positively associated with lipogenesis in adipocytes [4].
Recently, Frayn et al. have argued against this biochemical
mechanism[5]. They point out that fatty acid oxidation is not
a major pathway in white adipocytes and that oxygen con-
sumption by adipose tissue is insufficient to oxidise sub-
stantial amounts of fatty acids [6].
We fully agree with the point made by the authors that
fatty acid oxidation by adipocytes is not a major pathway
compared with muscle. However, we hold a different view
on the quantitative interpretation of these data: in our model
there is no need for a high rate of fatty acid oxidation in
adipose tissue per time unit, as fatty acid redistribution from
peripheral tissue to the liver is a slow process, taking several
years. For instance, in individuals in whom mitochondrial
copy number is acutely reduced as result of starting HAART,
it takes 18–24 months before redistribution of body fat
becomes clinically manifest [7].
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redistribution per time unit is very small. Thus, mito-
chondria in adipocytes only need to remove a small
amount of fatty acids per time unit to protect against
redistribution of body fat. By using the oxygen consump-
tion data of Frayn et al. and others [5, 6] or using similar
data from other studies [8, 9], one can calculate that oxygen
consumption by adipose tissue is sufficient to prevent
redistribution of >1.5 kg of fat out of 10 kg of peripheral
adipose tissue to the liver within a 3 year period, a realistic
clinical situation.
Therefore, in our opinion, adipose tissue is able to oxi-
dise substantial amounts of fatty acids over a long period by
mitochondrial beta oxidation. This process may over time
attenuate ectopic deposition of those fatty acids. Since
mitochondria also contribute to formation of glycerol 3-
phosphate, needed for re-esterification of fatty acids within
adipocytes, mitochondria in adipocytes have the ability to
protect the organism to a certain extent against leakage of
fatty acids into the circulation and thus, redistribution of
body fat. As Frayn et al. [5] have pointed out, brown adi-
pose tissue is indeed more active in uncoupled oxidative
disposal of fatty acids compared with white tissue. Recent
evidence also suggests that brown adipose tissue is present
in variable amounts and at multiple sites in humans,
contrary to earlier reports [10]. This recently recognised
situation further enhances the capacity of the adipose
compartment to remove fatty acids through uncoupled beta
oxidation.
In order to understand the mechanism by which
mitochondria in adipocytes contribute to the control of
body fat distribution during the development of the
metabolic syndrome, additional studies are needed, com-
prising quantification of fatty acid fluxes in relation to re-
esterification and oxidation in adipose tissue. These studies
should include study of adipose tissue from individuals
with normal glucose tolerance and from those with
developing glucose intolerance.
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